Emerging Infectious Disease Diagnostics Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Emerging Infectious Disease Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Emerging Infectious Disease Diagnostics Market Size During the Forecast Period?
The market size for diagnostic tools for emerging infectious diseases has seen substantial growth in recent years. It is projected to expand from $22.13 billion in 2024 to $24.34 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historic period is likely due to the escalating demand for point-of-care diagnostics, the rising prevalence of infectious diseases, the increase in global population density, a surge in incidents of infectious diseases, and a boost in healare spending.

Anticipated robust growth is expected in the upcoming years for the emerging infectious disease diagnostics market, with a projected escalation to $35.21 billion by 2029, marking a compound annual growth rate (CAGR) of 9.7%. The expansion in the prediction period is likely due to factors such as the increasing prevalence of zoonotic diseases, pronounced shifts and support in regulation, development of universal vaccines, an emphasized focus on the one health approach, and heightened government backing and funding. Key trends within this prediction period encompass technological innovations, advancements in next-generation sequencing (NGS), improvements in isothermal amplification techniques, the rise of telemedicine and remote diagnostics, as well as monitoring of environmental pathogens.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20548

What Are the High-Growth Segments in the Emerging Infectious Disease Diagnostics Market?
The emerging infectious disease diagnostics market covered in this report is segmented -

1) By Infection Type: Viral, Bacterial, Fungal, Other Infections
2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types
3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies
4) By Application: Laboratory Testing, Point-of-Care Testing
5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users

Subsegments:
1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections
2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria
3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections
4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20548&type=smp

What Key Drivers Are Expected to Influence Future Emerging Infectious Disease Diagnostics Market Growth?
The growth of the emerging infectious disease diagnostics market is expected to be fueled by the increasing prevalence of zoonotic diseases. These are diseases that can be passed on from animals to humans and can be caused by viruses, bacteria, parasites, or fungi. The escalation in the prevalence of zoonotic diseases can be attributed to enhanced human-wildlife interactions, habitat destruction, and international travel, which aid in spreading pathogens across species. Emerging infectious disease diagnostics play a crucial role in controlling zoonotic diseases by enabling early detection and precise identification of pathogens. This allows for timely intervention, efficient treatment, and improved containment of disease outbreaks, thus curbing the transmission from animals to humans. For instance, the 2022 Zoonotic Disease Report, published by State of West Virginia, a US government administration, stated in the MMWR Year 2022 that the count of reported Lyme disease cases in February 2024 had increased to 2,449 from 1,788 cases in 2021. Hence, the increasing prevalence of zoonotic diseases is the driving force behind the growth of the emerging infectious disease diagnostics market.

Which Companies Hold the Largest Share Across Different Emerging Infectious Disease Diagnostics Market Segments?
Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton inson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.

What Trends Are Driving Growth in The Anesthesia Circuits Market?
Leading firms in the emerging infectious disease diagnostics market are harnessing technological innovations, such as molecular diagnostic platforms, to secure their market position. These platforms employ nucleic acid amplification methods to identify pathogens with great precision and sensitivity, thereby ensuring accurate diagnoses and facilitating early detection. For example, in May 2022, Becton inson and Company, an American medical equipment manufacturer, unveiled the BD COR MX/PX System, a fully automated diagnostic platform with high throughput capabilities. By automating the entire molecular workflow starting from sample processing through to results, this system enhances laboratory efficiency. Its maiden assay, the BD CTGCTV2, can identify three common non-viral sexually transmitted infections (STIs). Capable of processing up to 1,700 specimens with onboard reagent and sample capacity, the BD COR MX/PX system offers over seven hours of unbroken operation, and can yield as many as 1,000 results within a single day, significantly lessening the manual workload for lab technicians.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/emerging-infectious-disease-diagnostics-global-market-report

What Are the Emerging Geographies for The Emerging Infectious Disease Diagnostics Market Growth?
North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Emerging Infectious Disease Diagnostics Market?
2. What is the CAGR expected in the Emerging Infectious Disease Diagnostics Market?
3. What Are the Key Innovations Transforming the Emerging Infectious Disease Diagnostics Industry?
4. Which Region Is Leading the Emerging Infectious Disease Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the emerging infectious disease diagnostics market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.